EligibleTrials

Effects of an Antioxidant Supplement on Blood Vessel Health

Recruiting · NCT06424756 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Georgia

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

L-NAMEMitoQMitoTempoPlaceboSNP - Sodium NitroprussideTempol

What this trial is about

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults, potentially predisposing them to the development of hypertension and CVD. This study is designed to examine whether the mitochondria are an important source of oxidative stress-induced vascular dysfunction in healthy NHB adults.

Who can take part

Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.